Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.2 USD | -3.32% | -24.35% | +116.22% |
May. 02 | Transcript : Cardiff Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Cardiff Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Cardiff Oncology, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Cardiff Oncology, Inc.
HC Wainwright | |
Piper Sandler | |
Baird | |
Maxim | |
William Blair & Co. |
EPS Revisions
- Stock Market
- Equities
- CRDF Stock
- Consensus Cardiff Oncology, Inc.